Name

Inspire

Legal name

INSPIRE s.r.l.

Website

https://inspire-srl.it

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Healthcare Analytics Software

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Software Publishers (5132), Custom Computer Programming Services (541511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF), Pharmacovigilance & Drug Safety Software (HLAGAJAK), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

• Predictive healthcare analytics
• Machine learning algorithms
• Chronic disease management
• Pharmacoepidemiology research
• Clinical decision support

Headquarters

HQ city

Messina

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Algorithmic Solutions Commercialization: Development and commercialization of innovative algorithms for pathology prediction and drug response analysis, both patentable and non-patentable solutions sold to healthcare institutions and pharmaceutical companies.
2. Healthcare Software and Hardware Products: Production and commercialization of hardware and software for chronic disease management sold to patients, healthcare operators, and institutions.
3. Research and Development Services: Research and experimentation services, including partnership projects with other companies or national/foreign entities for technological development in the healthcare sector.
4. Scientific Events and Training: Organization of scientific events, seminars, symposia, communication campaigns, training courses, editorial and information activities in medical and healthcare informatics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

INSPIRE develops proprietary machine learning algorithms for pathology prediction, drug response and benefit-risk analysis on real-world healthcare data, and ships a chronic pathology management software platform delivered via cross-platform mobile and web applications. The company also provides R&D project design and data-analysis support for pharmacoepidemiology and clinical research.

Product overview

INSPIRE s.r.l. offers a portfolio of healthcare technology products centered on its innovative algorithms for pathology prediction and chronic pathology management software. The core offering consists of machine learning algorithms that predict diseases and pharmacological treatment responses using big data analytics on healthcare databases. This is complemented by hardware and software solutions for managing chronic conditions targeting patients, healthcare operators, institutions, and pharmaceutical companies. Additionally, the company develops mobile applications and web applications as part of its ICT solutions for the healthcare sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Innovative Algorithms for Pathology Prediction Proprietary machine learning algorithms for predictive analysis of patient health data, including identification of patients at higher risk of complications, prediction of which drugs will be effective and well tolerated, analysis of drug benefit-risk profiles, and path-based prediction of risks based on patient history. Designed for healthcare institutions and pharmaceutical companies.
• Chronic Pathology Management Software Software product that supports the day-by-day clinical needs of patients affected by chronic pathologies, providing indications to doctors and caregivers for clinical decisions and helping patients follow the prescribed therapy and correct lifestyle. Aimed at patients with chronic conditions and the clinicians/caregivers managing their care.
• Cross-Platform Mobile and Web Applications Customized high-quality cross-platform mobile and web applications developed across multiple devices and operating systems (Android, iOS, Windows, web browsers), with support for tablets, smartphones, and PCs to satisfy customer requirements. Offered to healthcare and research customers needing tailored clinical and patient-facing applications.

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core and major.

• Università degli Studi di Messina (University of Messina)coreStrategic or Co-development Partner · 1 July 2020INSPIRE originated as a spin-off of the University of Messina, established in July 2020. The company maintains close ties with the Department of Biomedical Sciences and other university departments, providing access to research talent and academic resources.
• Università degli Studi di Verona (University of Verona)coreStrategic or Co-development Partner · 1 July 2020INSPIRE is accredited to the University of Verona, with Professor Gianluca Trifirò serving as Chairman of the Board. The company benefits from access to Verona's Department of Diagnostics and Public Health for research collaboration.
• RTI Health Solutions (Research Triangle Institute)majorStrategic or Co-development PartnerInternational research organization partner providing expertise in health outcomes research and pharmacoepidemiology, supporting INSPIRE's research capabilities.
• PHARMO Institute of Drug Outcomes ResearchmajorStrategic or Co-development PartnerDutch institute specializing in drug outcomes research, contributing to INSPIRE's pharmacoepidemiology capabilities and real-world evidence analysis.
• University Medical Center UtrechtmajorStrategic or Co-development PartnerAcademic medical center in the Netherlands providing clinical research collaboration opportunities and healthcare expertise.
• Ieeng Solution S.r.l.majorTechnology or IntegrationTechnology partner with decade-long experience in developing innovative platforms, mobile applications, and web applications. Ieeng Solution provides software development capabilities including platforms for COPD management, blood donor systems (smartDONOR), and participation in research projects like AEROMAT. They also designed and maintain the INSPIRE corporate website.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Flatiron Health: Real-world oncology data and analytics company acquired by Roche, comparable in its ML-on-healthcare-data approach to INSPIRE's drug response and disease prediction algorithms, though focused on oncology.
• TriNetX: Global health research network providing federated real-world patient data and analytics for pharma R&D and clinical research, overlapping with INSPIRE's RWD-driven ML pathology/drug-response prediction capabilities.
• Tempus Labs: AI-powered precision medicine company combining multi-modal healthcare data and ML for disease prediction and treatment response — overlapping with INSPIRE's predictive analytics positioning though at much larger scale.
• Owkin: Federated learning and AI biotech applying ML to clinical and biomedical data for drug discovery and patient stratification — a comparably sized emerging player in ML-driven health research.

Broad incumbents

• IQVIA: Largest life sciences analytics and real-world evidence incumbent, offering pharma R&D, pharmacovigilance, and health data analytics at global scale — a much larger, broader competitor to INSPIRE's niche offerings.
• Cytel: Established biostatistics and clinical analytics CRO serving pharma R&D, comparable to INSPIRE's biostatistics/informatics-heavy approach to drug development support and real-world evidence.
• Elsevier (Entellect / Pharmaceutical R&D analytics): Elsevier's pharmaceutical analytics suite (including Real-World Data and drug safety tools) competes with INSPIRE's pharmacovigilance and real-world evidence analytics for pharma customers.
• SAS (Health & Life Sciences): Major analytics platform vendor with a dedicated Health & Life Sciences practice covering biostatistics, pharmacovigilance, and clinical programming — adjacent incumbent to INSPIRE's statistical and informatics offerings.

Direct peers

• RTI Health Solutions: Research Triangle Institute's health outcomes arm is a Major-tier partner of INSPIRE and operates in the same pharmacoepidemiology, real-world evidence, and drug safety analytics space, serving pharma clients with comparable methodologies.
• PHARMO Institute for Drug Outcomes Research: Dutch institute specializing in drug outcomes research and real-world data analytics using large healthcare databases — directly comparable to INSPIRE's pharmacoepidemiology work and a current Major-tier partner.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/spin-off-inspire-srl

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inspire